For this position, the recruiting organisation is Vrije Universiteit Brussel (VUB) in Brussels, Belgium. The selected candidate will be employed by the Molecular Imaging and Therapy research group of VUB and will be embedded in the POLARIS consortium, with academic supervision provided by Prof. Timo De Groof and Prof. Nick Devoogdt.

Molecular Imaging and Therapy Research group, Vrije Universiteit Brussel, Belgium
The Molecular Imaging and Therapy (MITH) research group at Vrije Universiteit Brussel is internationally recognised for its expertise in nanobody discovery, engineering and translational applications. The group develops nanobody-based tools for molecular imaging, target validation and therapeutic innovation, combining antibody technologies with advanced in vitro and in vivo characterisation approaches. Within POLARIS, VUB contributes leading expertise in nanobody development and functional characterisation.
This doctoral project focuses on developing GPRC5B-targeting nanobodies for use as research tools, diagnostic tracers and/or therapeutics.
The candidate will generate and characterise nanobodies using immune and synthetic nanobody libraries, as well as AI-generated candidates. The project will involve in vitro and in vivo characterisation of the generated nanobodies, including assessment of their affinity, specificity, stability, biodistribution and modulatory effects. The candidate will also investigate the functional effects of nanobodies on GPRC5B signalling and contribute to their development as innovative tools and candidate therapeutic modalities for leukodystrophies.
Through the POLARIS network, the candidate will gain additional experience in nanobody engineering, AI-supported candidate generation and functional characterisation in relation to GPRC5B biology. Planned secondments and network-wide training activities will provide further interdisciplinary and intersectoral exposure.
The academic embedding will be at Vrije Universiteit Brussel, with full participation in the broader POLARIS doctoral training programme.
Important, strict eligibility criteria according to MARIE SKLODOWSKA CURIE programs apply to applicants:
- You must not already hold a doctoral degree.
- At the time of the application deadline, you must have a Master’s degree and must not have resided or carried out your main activity (work, studies, etc.) in Belgium for more than 12 months in the three years prior to the contract start date.
- You will participate in the network-wide training programme of POLARIS, which includes (international) training activities and planned secondments with POLARIS partner organizations throughout the EU.
We are looking for a motivated candidate with a Master’s degree in life sciences, preferably molecular sciences, biotechnology, biomedical sciences or a related field. You have a strong interest in antibody-based technologies, translational research and rare disease biology.
Experience in molecular biology, protein technologies, antibody engineering, cell-based assays or related experimental approaches is considered an advantage. Interest in receptor biology, GPCR signalling and the development of innovative biologics is highly relevant for this position. Experience with in vivo work, imaging approaches or quantitative characterisation methods would also be beneficial.
You work accurately and reproducibly, have strong analytical skills and are able to collaborate effectively in an interdisciplinary and international research environment.
- A contract for 12 months, with the intention to extend for a total of 3 years;
- Salary, mobility allowance and benefits according to the applicable MSCA Doctoral Network and host-organisation rules;
- Embedding in the international POLARIS doctoral training network;
- Access to network-wide training activities, secondments and transferable-skills development;
- A challenging and translational research project at the interface of nanobody discovery and engineering, GPCR biology and preclinical in vivo testing;
- A collaborative and entrepreneurial working environment;
- An open and supportive team culture with opportunities for scientific and professional development.
Applications for the doctoral positions have now closed. The selection process is currently ongoing, and applications are being reviewed by the recruiting institutions.
POLARIS is now moving into the next phase of its doctoral programme, which will bring together a new cohort of researchers working across disciplines and sectors to advance translational research in leukodystrophies.













